1-4 of 4
Hans Hagberg, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rituximab Plus Lenalidomide Versus Rituximab Monotherapy in Untreated Follicular Lymphoma Patients in Need of Therapy. First Analysis of Survival Endpoints of the Randomized Phase-2 Trial SAKK 35/10

Eva Kimby, MD professor, Stephanie Rondeau, MSc, Anna Vanazzi, MD, Bjorn Ostenstad, MD PhD, Ulrich J.M. Mey, MD, Daniel Rauch, MD, Björn E Wahlin, MD PhD, Felicitas Hitz, MD, Micaela Hernberg, MD, Ann-Sofie Johansson, MD, Peter de Nully Brown, MD PhD, Hans Hagberg, MD PhD, Andres J.M. Ferreri, MD professor, Andreas Lohri, MD professor, Urban Novak, MD, Thilo Zander, MD, Hanne Bersvendsen, MD, Mario Bergetzi, MD, Walter Mingrone, MD, Fatime Krasniqi, MD PhD, Stefan Dirnhofer, MD professor, Hanne Hawle, MD, Simona Berardi, PhD, Michele Ghielmini, MD professor, Emanuele Zucca
Journal: Blood
Blood (2016) 128 (22): 1099.
https://doi.org/10.1182/blood.V128.22.1099.1099
Published: 2016
Journal Articles

Valproate in Combination with Rituximab and CHOP As First Line Therapy in Diffuse Large B-Cell Lymphoma (VALFRID): Preliminary Results from a Phase I Trial with a Dose Expansion Cohort

Kristina Drott, MD PhD, Hans Hagberg, MD PhD, Thomas Relander, MD PhD, Cecilia Graffman, MD PhD, Johan Drott, PhD, Mats Jerkeman, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3939.
https://doi.org/10.1182/blood.V126.23.3939.3939
Published: 2015
Journal Articles

Third Generation CD19-CAR T Cells for Relapsed and Refractory Lymphoma and Leukemia Report from the Swedish Phase I/IIa Trial

Gunilla Enblad, MDPhD, Hannah Karlsson, PhD, Kristina Wikstrom, PhD, Magnus Essand, PhD, Barbara Savoldo, MD PhD, Malcolm K. Brenner, MD PhD, Gianpietro Dotti, MD, Helene Hallbook, MDPhD, Martin Hoglund, MD PhD, Hans Hagberg, MD PhD, Angelica Loskog, PhD
Journal: Blood
Blood (2015) 126 (23): 1534.
https://doi.org/10.1182/blood.V126.23.1534.1534
Published: 2015
Journal Articles

Increased Risk for EBV-Lymphoma after Allogeneic Hsct in Adult Lymphoma Patients?A Retrospective Study of Reduced Compared to Myeloablative Conditioning.

Hans G. Hagglund, MD, PhD, Mats Brune, MD, PhD, Gunnar Oberg, MD, PhD, Hans Hagberg, MD, PhD, Niklas Theorin, MD, Mats Remberger, PhD, Eva Kimby, MD, PhD.
Journal: Blood
Blood (2004) 104 (11): 5116.
https://doi.org/10.1182/blood.V104.11.5116.5116
Published: 2004